Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71,941,794
-
Number of holders
-
309
-
Total 13F shares, excl. options
-
67,340,267
-
Shares change
-
+1,347,823
-
Total reported value, excl. options
-
$6,364,939,261
-
Value change
-
+$134,188,764
-
Put/Call ratio
-
42.12%
-
Number of buys
-
182
-
Number of sells
-
-115
-
Price
-
$94.52
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q2 2017
337 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q2 2017.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 309 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67,340,267 shares
of 71,941,794 outstanding shares and own 93.6% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (9,286,353 shares), VANGUARD GROUP INC (6,555,351 shares), BlackRock Inc. (6,217,894 shares), FRANKLIN RESOURCES INC (3,931,448 shares), Neuberger Berman Group LLC (3,746,266 shares), Select Equity Group, L.P. (3,144,729 shares), STATE STREET CORP (2,511,108 shares), JPMORGAN CHASE & CO (2,009,406 shares), BAMCO INC /NY/ (1,806,120 shares), and EAGLE ASSET MANAGEMENT INC (1,099,643 shares).
This table shows the top 309 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.